Remote Home Monitoring of Patients With Cancer During the COVID Pandemic: A Pilot Study

The COVID-19 pandemic has spurred cancer teams to find new ways to care safely for patients with cancer, in particular outpatients who have tested positive for COVID-19 but do not require hospitalization. Inova Schar Cancer Institute’s physicians and advanced practice providers utilized a program called remote patient monitoring (RPM) to observe COVID-positive outpatients. To study whether or not this program would be effective, they monitored the patients through the use of automatic blood pressure cuffs, oral thermometers, finger pulse oximeters, and a configured computer tablet to enter vital signs and answer assessment questions. At the conclusion of the study, it was found that RPM may be used as a tool for monitoring outpatients with mild symptoms during the COVID-19 pandemic.

Providers Involved: Mary Steimer, NP; Jessica Leabo, PA-C; Hongkun Wang, Ph.D; David Heyer, MD; Nancy Addison, BSN; Nancy Bowles, BSN, MHA; Timothy L. Cannon, MD; Raymund Cuevo, MD; William B. Ershler, MD; Danielle Shafer, DO; Sekwon Jang, MD; Angela Pennisi, MD, Ph.D; Amjaad Al-Hussain, MHSA; Kirby Farrell, BA; and John F. Deeken, MD

View the study: Remote Home Monitoring of Patients With Cancer During the COVID Pandemic: A Pilot Study (JCO Oncology Practice, An American Society of Clinical Oncology Journal)